Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis

Mental disorders are associated with premature mortality. There is increasing research examining life expectancy and years-of-potential-life-lost (YPLL) to quantify the disease impact on survival in people with mental disorders. We aimed to systematically synthesize studies to estimate life expectancy and YPLL in people with any and specific mental disorders across a broad spectrum of diagnoses. In this systematic review and meta-analysis, we searched Embase, MEDLINE, PsychINFO, WOS from inception to July 31, 2023, for published studies reporting life expectancy and/or YPLL for mental disorders. Criteria for study inclusion were: patients of all ages with any mental disorders; reported data on life expectancy and/or YPLL of a mental-disorder cohort relative to the general population or a comparison group without mental disorders; and cohort studies. We excluded non-cohort studies, publications containing non-peer-reviewed data or those restricted to population subgroups. Survival estimates, i.e., life expectancy and YPLL, were pooled (based on summary data extracted from the included studies) using random-effects models. Subgroup analyses and random-effects meta-regression analyses were performed to explore sources of heterogeneity. Risk-of-bias assessment was evaluated using the Newcastle–Ottawa Scale. This study is registered with PROSPERO (CRD42022321190). Of 35,865 studies identified in our research, 109 studies from 24 countries or regions including 12,171,909 patients with mental disorders were eligible for analysis (54 for life expectancy and 109 for YPLL). Pooled life expectancy for mental disorders was 63.85 years (95% CI 62.63–65.06; I2 = 100.0%), and pooled YPLL was 14.66 years (95% CI 13.88–15.98; I2 = 100.0%). Disorder-stratified analyses revealed that substance-use disorders had the shortest life expectancy (57.07 years [95% CI 54.47–59.67]), while neurotic disorders had the longest lifespan (69.51 years [95% CI 67.26–71.76]). Substance-use disorders exhibited the greatest YPLL (20.38 years [95% CI 18.65–22.11]), followed by eating disorders (16.64 years [95% CI 7.45–25.82]), schizophrenia-spectrum disorders (15.37 years [95% CI 14.18–16.55]), and personality disorders (15.35 years [95% CI 12.80–17.89]). YPLLs attributable to natural and unnatural deaths in mental disorders were 4.38 years (95% CI 3.15–5.61) and 8.11 years (95% CI 6.10–10.13; suicide: 8.31 years [95% CI 6.43–10.19]), respectively. Stratified analyses by study period suggested